DECEMBER - JANUARYLIFE SCIENCES REVIEW5LAST WORDFabiana d'Aniello, PhD,R&D Portfolio Management Director, FerrerDrug Development for Rare Diseases34Rafael Sande,Head Operations Characterization Large Molecule /Cell- and Gene Therapy Services,Solvias AGEarly Phase Biologics Characterization; a Key Factor for Risks Mitigation in Biologics Product Developments28CXO INSIGHTSLuis Martin,Co-founder and CEO24CancerAppyThomas Lines,CEO32Quercis PharmaProf Dr. Mart Saarma,Senior Partner, Member of Board of Directors30GeneCode LtdPaavo Pilv,CEO,Member of Management BoardMarina Roussaki,Senior Scientific Project Manager26CloudpharmSofia Tsatsouli,New Product Development ManagerDRUG DISCOVERYAND DEVELOPMENTSOLUTIONS PROVIDERS IN EUROPE - 2023TOP 10Stefano Biondi,Head of Pre-Clinical,Recordati S.p.A.Navigating Through Drug Discovery and Development22
< Page 4 | Page 6 >